BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10837936)

  • 1. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?
    Freeman CR; Kepner J; Kun LE; Sanford RA; Kadota R; Mandell L; Friedman H
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):561-4. PubMed ID: 10837936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.
    Mandell LR; Kadota R; Freeman C; Douglass EC; Fontanesi J; Cohen ME; Kovnar E; Burger P; Sanford RA; Kepner J; Friedman H; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):959-64. PubMed ID: 10192340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833.
    Kretschmar CS; Tarbell NJ; Barnes PD; Krischer JP; Burger PC; Kun L
    Cancer; 1993 Aug; 72(4):1404-13. PubMed ID: 8339231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group.
    Freeman CR; Bourgouin PM; Sanford RA; Cohen ME; Friedman HS; Kun LE
    Cancer; 1996 Feb; 77(3):555-62. PubMed ID: 8630965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
    Korones DN; Fisher PG; Kretschmar C; Zhou T; Chen Z; Kepner J; Freeman C
    Pediatr Blood Cancer; 2008 Feb; 50(2):227-30. PubMed ID: 17278121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study.
    Freeman CR; Krischer JP; Sanford RA; Cohen ME; Burger PC; del Carpio R; Halperin EC; Munoz L; Friedman HS; Kun LE
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):197-206. PubMed ID: 8407392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group.
    Lewis J; Lucraft H; Gholkar A
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):925-9. PubMed ID: 9276356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy.
    Jennings MT; Freeman ML; Murray MJ
    J Neurooncol; 1996; 28(2-3):207-22. PubMed ID: 8832463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.
    Packer RJ; Boyett JM; Zimmerman RA; Albright AL; Kaplan AM; Rorke LB; Selch MT; Cherlow JM; Finlay JL; Wara WM
    Cancer; 1994 Sep; 74(6):1827-34. PubMed ID: 8082086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse brain stem gliomas. Are we improving outcome?
    Shuper A; Kornreich L; Loven D; Michowitz S; Schwartz M; Cohen IJ
    Childs Nerv Syst; 1998 Oct; 14(10):578-81. PubMed ID: 9840382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma.
    Kleinberg L; Grossman SA; Piantadosi S; Zeltzman M; Wharam M
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):535-43. PubMed ID: 10348282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study.
    Bernier-Chastagner V; Grill J; Doz F; Bracard S; Gentet JC; Marie-Cardine A; Luporsi E; Margueritte G; Lejars O; Laithier V; Mechinaud F; Millot F; Kalifa C; Chastagner P
    Cancer; 2005 Dec; 104(12):2792-7. PubMed ID: 16265674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concomitant chemoradiotherapy and malignant glial tumors in the adult].
    Honnorat J
    Cancer Radiother; 1998 Dec; 2(6):672-8. PubMed ID: 9922772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y
    Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
    Walter AW; Gajjar A; Ochs JS; Langston JW; Sanford RA; Kun LE; Heideman R
    Med Pediatr Oncol; 1998 Jan; 30(1):28-33. PubMed ID: 9371386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.